- Home
- SHPH
as 10-04-2024 4:00pm EST
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | GAITHERSBURG |
| Market Cap: | 3.1M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 141.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.13 - $5.35 | Next Earning Date: | 11-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Shuttle Pharmaceuticals Holdings Inc. News
SHPH Breaking Stock News: Dive into SHPH Ticker-Specific Updates for Smart Investing
MT Newswires
15 days ago
Shuttle Pharmaceuticals Launches Equity Offering
GlobeNewswire
19 days ago
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
ACCESSWIRE
24 days ago
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
GlobeNewswire
a month ago
Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
GlobeNewswire
a month ago
Shuttle Pharma Provides Second Quarter 2024 Corporate Update
MT Newswires
a month ago
Shuttle Pharmaceuticals Regains Nasdaq Compliance
GlobeNewswire
a month ago
Shuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
a month ago
Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)
Compare SHPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SHPH Shuttle Pharmaceuticals Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.